The biomaterials industry is driven by novel materials which form three dimensional porous scaffolds possessing nano/microscale structures that are biocompatible and promote the growth of living cells.

Current commercial products vary considerably, from both biological and synthetic polymers and are available in different forms such as powders, gels, membranes and pastes. The vast majority of the biomaterials in current clinical use are derived from animal or human tissue, raising ethical concerns about the processes employed to acquire the source tissue as well as the human/animal welfare controls.

Our product is derived from cell wall architectures found in the plant and fungus kingdoms. Using highly evolved plant tissue, we are able to create complex 3D scaffolds that promote cell infiltration, cell growth, angiogenesis and tissue repair and reconstruction. We are developing premade biomaterials for immediate use.